PRAX
Praxis Precision Medicines Inc
NASDAQ: PRAX · HEALTHCARE · BIOTECHNOLOGY
$323.19
+0.39% today
Updated 2026-04-29
Market cap
$9.00B
P/E ratio
—
P/S ratio
953.14x
EPS (TTM)
$-13.47
Dividend yield
—
52W range
$35 – $356
Volume
0.4M
Praxis Precision Medicines Inc (PRAX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | $19.83M | $47.69M | $303.18M | $292.75M | $115.13M | $87.95M | $483.11M |
| Cash & equivalents | — | — | — | — | — | — | — |
| Current assets | $19.13M | $45.50M | $302.33M | $287.41M | $110.84M | $84.88M | $404.37M |
| Total liabilities | $5.15M | $7.58M | $15.72M | $41.94M | $39.02M | $18.28M | $37.66M |
| Current liabilities | $5.14M | $6.82M | $15.72M | $37.62M | $35.52M | $15.75M | $37.55M |
| Long-term debt | — | — | — | — | — | — | — |
| Shareholder equity | — | — | — | — | — | — | — |
| Retained earnings | $-41.37M | $-81.01M | $-149.55M | $-316.62M | $-530.64M | $-653.92M | $-836.74M |
| Accounts receivable | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — |